Daihan PharmaceuticalLtd Dividends and Buybacks
Dividend criteria checks 2/6
Daihan PharmaceuticalLtd is a dividend paying company with a current yield of 2.88%.
Key information
2.9%
Dividend yield
2.2%
Buyback Yield
| Total Shareholder Yield | 5.1% |
| Future Dividend Yield | 3.5% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩750.000 |
| Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Here's Why Daihan PharmaceuticalLtd (KOSDAQ:023910) Can Manage Its Debt Responsibly
Mar 02
Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Feb 09
Can You Imagine How Daihan PharmaceuticalLtd's (KOSDAQ:023910) Shareholders Feel About The 34% Share Price Increase?
Jan 19What Kind Of Shareholders Hold The Majority In Daihan Pharmaceutical Co.,Ltd.'s (KOSDAQ:023910) Shares?
Dec 18Does Daihan PharmaceuticalLtd (KOSDAQ:023910) Have A Healthy Balance Sheet?
Nov 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A023910 has been paying a dividend for less than 10 years.
Growing Dividend: A023910's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Daihan PharmaceuticalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A023910) | 2.9% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A023910) (up to 3 years) | 3.5% |
Notable Dividend: A023910's dividend (2.88%) is higher than the bottom 25% of dividend payers in the KR market (1.23%).
High Dividend: A023910's dividend (2.88%) is low compared to the top 25% of dividend payers in the KR market (3.95%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A023910's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (28.3%), A023910's dividend payments are well covered by cash flows.